Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Corticobasal Degeneration.

Panida Piboolnurak1, Cheryl H. Waters

  • 1*The Neurological Institute, Columbia University, 710 West 168th Street, New York, NY 10032, USA. cw345@columbia.edu

Current Treatment Options in Neurology
|March 12, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuroimaging markers of motor and nonmotor features of Parkinson's disease: an 18f fluorodeoxyglucose positron emission computed tomography study.

Dementia and geriatric cognitive disorders·2013
Same author

Clinical characteristics of exacerbations in Parkinson disease.

The neurologist·2012
Same author

Unilateral subdural motor cortex stimulation improves essential tremor but not Parkinson's disease.

Brain : a journal of neurology·2011
Same author

Clinical predictors of frequent patient telephone calls in Parkinson's disease.

Parkinsonism & related disorders·2010
Same author

Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society·2007
Same author

Psychogenic tremor disorders identified using tree-based statistical algorithms and quantitative tremor analysis.

Movement disorders : official journal of the Movement Disorder Society·2005
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Corticobasal degeneration is a neurodegenerative tauopathy characterized by abnormal tau protein buildup. Current treatments manage symptoms, but effective therapies require further research into the disease's pathogenesis and molecular biology.

Area of Science:

  • Neurology
  • Neuroscience
  • Pathology

Background:

  • Corticobasal degeneration (CBD) is a type of neurodegenerative tauopathy.
  • CBD is characterized by abnormal tau protein accumulations in brain cells.
  • It presents as a heterogeneous group of dementias and movement disorders.

Purpose of the Study:

  • To summarize the current understanding of Corticobasal degeneration.
  • To highlight the need for further research into CBD pathogenesis and molecular biology.
  • To inform about the current state of therapeutic development for CBD.

Main Methods:

  • Literature review of neurodegenerative tauopathies, focusing on Corticobasal degeneration.
  • Analysis of neuropathological characteristics of CBD.

Related Experiment Videos

  • Overview of current and developing therapeutic strategies.

    • Main Results:

    • Corticobasal degeneration is defined by intracellular tau protein accumulations.
    • No curative treatments currently exist for CBD.
    • Symptomatic management offers some benefit.

    Conclusions:

    • Further investigation into the pathogenesis and molecular biology of Corticobasal degeneration is crucial.
    • Development of effective therapies for CBD is contingent upon deeper scientific understanding.
    • Ongoing research holds promise for future therapeutic advancements.